Fresenius Kabi launches Methocarbamol Injection in US for acute musculoskeletal conditions

pharmanewsdaily- February 12, 2019 0

Fresenius Kabi, the global German healthcare company, has unveiled Methocarbamol Injection, USP in the United States, marking a significant expansion of its anesthesia and analgesia ... Read More